OrbiMed Advisors LLC's Form 4 filing
Compass Therapeutics, Inc. (CMPX) · filed May 10, 2022
- Accession no.
- 0000947871-22-000540
- Filed
- May 10, 2022, 6:21 PM ET
- Trade date
- May 6-10, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $197.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director, 10% Owner |
| OrbiMed Capital GP V LLCCIK 0001615374 | Director, 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 6, 2022 | Common Stock | PPurchaseAcquired | +10,200 | $1.63 | +$16,626 | 14,510,319 | Indirect | Duplicate filing |
| May 9, 2022 | Common Stock | PPurchaseAcquired | +90,712 | $1.56 | +$141,510.72 | 14,601,031 | Indirect | Duplicate filing |
| May 10, 2022 | Common Stock | PPurchaseAcquired | +24,447 | $1.60 | +$39,115.2 | 14,625,478 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.